Drug Eluting Stents Market is poised to value over CAGR of over 6.4% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Eluting Stents Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Drug Eluting Stents Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Rising geriatric population, unhealthy food habits, sedentary lifestyle and a lack of exercise are some of the key factors driving the drug eluting stents market growth. Additionally, the drastic shift to DES from angioplasty for treating atherosclerosis across the world has significantly boosted the market growth. Furthermore, the DS technique is minimally invasive which shall propel the proliferation of the market. On the other hand, the risks in implementing DES technique such as endothelial tissues regrowth disruption and stent thrombosis shall restrain the proliferation of the market. 

Major players included in the Drug Eluting Stents Market:
• Boston Scientific Corporation
• Medtronic, Plc.
• Abbott Laboratories
• Biosensors International Group
• Biotronik
• Lepu Medical Technology
• Terumo Medical Corporation
• Cook Medical
• Shandong JW Medical Systems
• Stentys
• Abbott Vascular Inc.
• AlviMedica Medical Technologies Inc.
• Amaranth Medical, Inc.
• HangZhou HuaAn Biotechnology Co.,Ltd
• Xtent, Inc.
• Cardionovum GmbH
• Cordis Corporation
• Kyoto Medical Planning Co., Ltd.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Drug Eluting Stents Market Segmentation:

By Drug
• Sirolimus
• Paclitaxel
• Zotarolimus 
• Everolimus
• Biolimus 
• Others

By Coating Type
• Polymer-based Coatings
• Polymer-free Coatings

By Application
• Coronary Artery Disease
• Peripheral Artery Disease

By End User
• Cardiology Centers
• Ambulatory Surgery Centers (ASCs)
• Hospitals

By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

Regional Analysis:

The North America region expected to dominate the global market, and this can be credited to stringencies in guidelines for medical device approval and manufacturing. Additionally, improved reimbursement coverage along with high rate of incidence of artery diseases has bolstered the proliferation of the market. 

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:
•    To provide with an exhaustive analysis on the global drug eluting stents market By Drug, By Coating Type, By Application, By End User and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics